Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Contingent Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Contingent Liabilities ₹92 Cr₹72 Cr₹61 Cr₹0.34 Cr₹0.26 Cr

What is the latest Contingent Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Contingent Liabilities ratio of NATH BIOGENES (INDIA) is ₹92 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹92 Cr
Mar2023₹72 Cr
Mar2022₹61 Cr
Mar2013₹0.34 Cr
Mar2012₹0.26 Cr

How is Contingent Liabilities of NATH BIOGENES (INDIA) Trending?

Years Contingent Liabilities % Change
Mar2024 ₹92 Cr
28.60
Mar2023 ₹72 Cr
18.58
Mar2022 ₹61 Cr
17,668.04
Mar2013 ₹0.34 Cr
33.73
Mar2012 ₹0.26 Cr -

Compare Contingent Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹377.2 Cr -2.4% 5.6% -1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,934.7 Cr -5.8% -6.3% 14.7% Stock Analytics
KAVERI SEED COMPANY ₹6,436.8 Cr -5.7% -15.3% 32.9% Stock Analytics
VENKYS (INDIA) ₹2,264.3 Cr -1.5% 0.4% -16.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,435.5 Cr -2% -1.8% -33.7% Stock Analytics
INDO US BIOTECH ₹307.9 Cr 1.5% 1.6% -27% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.4%

5.6%

-1%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses